Patient Access to Innovative New Technologies Act of 2025
Patient Access to Innovative New Technologies Act of 2025
Plain Language Summary
# Patient Access to Innovative New Technologies Act of 2025 (HR 4441) **What the Bill Would Do:** This bill, introduced by Representative Mike Carey (R-OH), aims to improve patient access to new medical technologies and treatments. While the full details aren't publicly specified in the available information, bills with this title typically focus on streamlining FDA approval processes or reducing barriers that patients face when trying to access newly developed medical devices, drugs, or procedures that aren't yet widely available. **Who It Affects and Current Status:** The bill would potentially impact patients seeking cutting-edge medical treatments, healthcare providers, medical device manufacturers, and pharmaceutical companies. It could also affect the FDA's regulatory processes.
As of now, the bill is in committee, meaning it's still in the early stages of consideration and hasn't yet been debated or voted on by the full House of Representatives. **Note:** Without access to the bill's specific text and detailed provisions, this summary reflects the general intent suggested by the bill's title. For complete information about what the bill actually proposes, you can view the full text on Congress.gov.
Latest Action
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.